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Research Article
Prevalence of methicillin resistance and virulence determinants of 
Staphylococcus aureus in diabetic foot ulcers
Sumeet Sandhu, Irani Udeshika Rathnayake, Flavia Huygens*
INTRODUCTION
Diabetes mellitus is the most commonly encountered health 
problem worldwide.1 Studies have shown that 6-8% of the 
adult population worldwide is diagnosed with diabetes.2 
According to World Health Organization reports, the 
prevalence of this condition will double by the year 2025. 
It is the metabolic disorder, which damages target organs 
and is characterized by chronic hyperglycemia.3 One of the 
most common complications associated with diabetes is 
diabetic foot ulcer (DFU), which accounts for around 20% 
of hospital admissions around the world.4,5 Furthermore, 
DFUs are one of the most common causes of lower limb 
amputations, prolonged outpatient care and hospitalization. 
It is estimated that about 15% of all the diabetic patients 
develop foot ulcers during their lifetime.4,6
Infection is one of the complications associated with DFUs, 
and an infected DFU is also the second major cause of 
amputation.3 Bacterial colonization occurs in deep tissues 
once the protective layer of the skin is broken.1 Therefore, 
DFUs are highly prone to infections. Once the bacterial 
infection occurs, it rapidly spreads and leads to severe 
destruction of tissues that requires subsequent amputation.1,6-9 
Despite the presence of various mixed (Gram-positive 
and Gram-negative) bacterial species in DFUs, the most 
frequently isolated species is Staphylococcus aureus.1 
S. aureus is considered to be the major pathogen causing 
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DFU infections and it is also one of the most adaptable human 
pathogens responsible for causing a wide range of illnesses.10
A major threat to public health is the increasing prevalence 
of antimicrobial resistance which occurs due to excess usage 
of antibiotics.11 In 15-30% of DFUs, methicillin-resistant 
S. aureus (MRSA) are isolated.12 Different factors are 
responsible for this resistance but mainly it is due to 
inappropriate antibiotic treatment and poor hygiene.6 
Infrequent patient contact and follow-up has also contributed 
to resistance development as they may encourage the 
clinician to overprescribe.13 The virulence potential of 
S. aureus present in DFUs is also a factor, which can 
contribute to wound severity as these factors enables this 
pathogen to access and destroy the host tissue.
The aim of the present study was to detect the presence 
of S. aureus in infected DFUs along with its virulence 
and antibiotic resistance profiles. An understanding of the 
pathogenic and antibiotic resistance profiles of S. aureus in 
DFUs will assist health professionals to manage this ailment 
more efficiently by using targeted therapy.
Aims and objectives
• To detect the presence of S. aureus in DFU samples 
using molecular methods
• To determine the prevalence of MRSA in DFUs
• To determine the virulence profile of S. aureus in DFUs.
METHODS
DFU swab samples were collected from 30 patients at 
different time points (from March-October 2012) using 
the Z-swab technique. All swabs were kept at 4°C until 
transported to the laboratory, whereupon they were stored 
at −80°C until further analysis.
DNA extraction
DNA was extracted from S. aureus ATCC control strains 
(ATCC 29213 and USA 300) and patient swabs using an 
optimised Qiagen protocol as per manufacturer’s guidelines.
Detection of S. aureus and its methicillin resistance and 
virulence determinants in DFUs
The gene for S. aureus speciation was nucA and mecA for 
methicillin resistance. Virulence gene targets included: 
Panton–Valentine leukocidin (PVL), alpha toxin, exfoliatin 
factor A (exfA), fibronectin factor A (fnbA) and fibronectin 
factor B (fnbB). Primers were selected from previously 
published studies (Table 1). After primer optimization, DNA 
extracted from wound swabs was subjected to individual 
polymerase chain reaction (PCR) reaction conditions 
depending on the targeted gene.
PCR reaction for S. aureus (nucA, mecA, PVL, alpha 
toxin, exfA, fnbA and fnbB)
Each 25 µl PCR reaction contained 2 µl of DNA which 
was added to 23 µl of master mix containing 0.1 µl of Taq 
polymerase (Roche, Australia), 0.5 µl of dNTPs (Roche, 
Australia), 0.625 µl each of reverse and forward primers 
(Table 2) (Sigma Aldrich, Australia), 1.5 µl of MgCl2 (Roche, 
Australia), 2.5 µl of 10X PCR buffer (Roche, Australia) 
and 17.15 µl of water (DNAse and RNAse free - Life 
Technologies, Australia). PCR was performed using the 
program, including initial denaturation at 95°C for 10 mins, 
followed by 30 cycles of annealing and extension (72°C for 
30 sec). An annealing temperature of 55°C was used for 
nucA and mecA gene amplification. 60°C was used as an 
annealing temperature for alpha toxin, fnbA and fnbB genes. 
exfA gene was amplified using an annealing temperature 
of 49°C. Final extension was carried out for 5 mins at 
72°C. The PCR products were visualized using agarose gel 
(2%) electrophoresis. Gel images were captured using the 
GeneSnap program of G: BOX gel documentation system, 
Syngene Australia.
RESULTS
This study included a total of 30 diabetic patients with 
DFUs. The concentration of DNA extracted from 223 swab 
samples ranged from 2 to 80 ng/µl. PCR was used to detect 
and characterize the commonly detected microbial species 
S. aureus from DFUs. It was found that 44.8% of DFU 
swab samples were positive for the nucA gene confirming 
the presence of S. aureus in these samples. All the S. aureus 
positive samples were examined further for the presence of 
MRSA by targeting the mecA gene. 25% of S. aureus positive 
samples were found to be MRSA. None of the S. aureus 
positive samples were positive for PVL. The alpha toxin gene 
was detected in 85% of the S. aureus positive samples, and 
the exfA gene was detected in 61% of the S. aureus positive 
samples. For the fnbA and fnbB genes, 71% and 74% of 
the S. aureus positive samples were positive for these two 
genes (Figure 1). PHF$ $OSKDWR[LQ H[I$ IQE$ IQE% 39/3HUFHQWDJH 7DUJHWJHQHV
Figure 1: Methicillin resistance and virulence profile 
of Staphylococcus aureus present in diabetic foot 
ulcerations.
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DISCUSSION
From the 30 patients recruited, 223 DFU swab samples 
were analyzed for the presence of S. aureus. The majority 
of previous studies have documented that S. aureus is the 
most commonly isolated Gram-positive bacteria from 
infected DFU.1,2,12-16 An Indian study showed that S. aureus 
was present in 21% of a total of 112 samples.3 Our results 
show that 66.6% of diabetic patients had S. aureus in their 
foot ulcers, and 44.8% of all the DFU swab samples were 
positive for S. aureus. This data are similar to what has 
been reported previously in a study performed at the Royal 
Melbourne Hospital in 2009 by Yates et al., however, their 
study used traditional culture-based methods.17
S. aureus has a number of virulence factors that facilitates 
the infection of soft tissues and bones. PVL is one of these 
virulence traits, and it seems to be associated with severely 
infected DFUs.18 In our study, none of the DFU patient 
samples were positive for PVL. Alpha-toxin is considered 
to be the most renowned S. aureus toxin and it has cytolytic 
activity.19 Its role in DFU infection is not well documented 
in the literature. We found that this toxin was present in 
85% of S. aureus positive DFU swab samples. One of the 
previous studies have reported that the exfA gene was absent 
in their DFU samples.20 In our study, exfA was detected in 
61% of the S. aureus positive DFU swab samples. fnbA 
and fnbB are members of microbial surface components 
recognizing adhesive matrix molecules family and mediate 
S. aureus adhesion to the host cell. In our study, fnbA gene 
was present in 71% of S. aureus positive DFU swab samples 
and the fnbB gene was present in 74% of S. aureus positive 
DFU swab samples.
DFUs are found to be increasingly inhabited with MRSA.21 
A major health threat to the hospital and community setting 
is the increasing frequency of MRSA isolation from DFU. 
The majority of findings have shown that the prevalence of 
MRSA among diabetic patients with infected foot ulcers is 
15-30%.2,22,23 In the United Kingdom, a study was conducted 
in which 30% of all cultured DFUs had MRSA. This MRSA 
colonization was linked to prior antibiotic usage, and it 
Table 2: Oligonucleotide primers used in this study.
Target species Gene Forward primer Reverse primer Reference
S. aureus nucA 5’GCGATTGATGG 
TGATACGGTT3’
5’AGCCAAGCCTTGA 
CGAACTAAAGC3’
Huygens et al., 
200624
mecA 5’GATCGCAACG 
TTCAATTTAATTTTG3’
5’GCTTTGGTCTTTCT 
GCATTCCT3’
Huygens et al., 
200624
PVL 5’TATCTCTAACGG 
CTTGTCAGGT3’
5’TGCTTCAACA 
TCCCAACC3’
Huygens et al., 
200624
alpha-toxin 5’GACCAGCAATGG 
TACCTTTC3’
5’GCTAATGCCGC 
AGATTCTG3’
Unpublished 
(Huygens et al.)
exfA 5’GGCTAATAACAC 
TTCGATAA3’
5’CAGGACTAGTC 
TTAGGATTA3’
Unpublished 
(Huygens et al.)
fnbA 5’CCACCTGGGTTT 
GTATCTTCTTC3’
5’GATTACCACACAGC 
TATAGATGGTG3’
Unpublished 
(Huygens et al.)
fnbB 5’CGTGACCATTTTCA 
GTTCCTAAACC3’
5’GATACAAACCC 
AGGTGGTGG3’
Unpublished 
(Huygens et al.)
PVL: Panton-Valentine leukocidin, exfA: Exfoliatin factor A, fnbA: Fibronectin factor A, fnbB: Fibronectin factor B, 
S. aureus: Staphylococcus aureus
Table 1: Prevalence of S. aureus in DFUs.
Country S. aureus prevalence (%) 
in infected DFUs
MRSA prevalence (%) 
in infected DFUs
References
USA 35.5 12.0 Ge et al., 200225
Santa Monica 76.0 20.0 Goldstein et al., 199622
UAE 28.0 8.1 El-Tahawy., 200026
UK 48.3 30.2 Tentolouris et al., 199927
Kuwait 38.4 5.9 Abdulrazak et al., 200528
UK 42.0 19.0 Stanaway et al., 200729
Spain 47.5 19.9 Aragón-Sánchez., 200830
France 36 19.7 Richard et al., 200815
India 75 60 Mehta et al., 201431
S. aureus: Staphylococcus aureus, DFU: Diabetic foot ulceration, MRSA: Methicillin resistant S. aureus
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adversely affected the wound healing process.3 In our study, 
we have found that 25% of all the S. aureus positive samples 
were MRSA. This trend is similar to that found by Yates et al. 
(2009), who isolated MRSA from 23% of DFUs. The factors 
predisposing to MRSA infection include chronic duration of 
DFU and prolonged use of antibiotics.17
The rationale for targeting only S. aureus in our study is 
based on its increasing prevalence in DFUs, as described 
by previously published studies (Table 2). Our study reports 
the prevalence of S. aureus, MRSA and associated S. aureus 
virulence factors using molecular methods. To the best of 
our knowledge, this is the first Queensland study which has 
used molecular methods to characterize the virulence and 
methicillin resistance traits of S. aureus associated with 
DFUs.
ACKNOWLEDGMENTS
We acknowledge the assistance of Dr. Melissa Fernandez and 
Mr. Arnulf Compay for sample collection and preparation 
of the ethics application.
Funding: Australia-India Strategic Research Fund (AISRF)
Conflict of interest: None declared
Ethical approval: Approval was obtained from the QUT’s 
Ethics Committee prior to the commencement of this study
REFERENCES
1. Mendes JJ, Marques-Costa A, Vilela C, Neves J, Candeias N, 
Cavaco-Silva P, et al. Clinical and bacteriological survey of 
diabetic foot infections in Lisbon. Diabetes Res Clin Pract. 
2012;95(1):153-61.
2. Eleftheriadou I, Tentolouris N, Argiana V, Jude E, 
Boulton AJ. Methicillin-resistant Staphylococcus aureus in 
diabetic foot infections. Drugs. 2010;70(14):1785-97.
3. Pappu AK, Sinha A, Johnson A. Microbiological profile of 
diabetic foot ulcer. Calicut Med J. 2011;9:1-4.
4. Frykberg RG. An evidence-based approach to diabetic foot 
infections. Am J Surg. 2003;186(5A):44S-54.
5. Roberts AD, Simon GL. Diabetic foot infections: the role 
of microbiology and antibiotic treatment. Semin Vasc Surg. 
2012;25(2):75-81.
6. Kandemir O, Akbay E, Sahin E, Milcan A, Gen R. Risk 
factors for infection of the diabetic foot with multi-antibiotic 
resistant microorganisms. J Infect. 2007;54(5):439-45.
7. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, 
Rhoads D. Polymicrobial nature of chronic diabetic foot 
ulcer biofilm infections determined using bacterial tag 
encoded FLX amplicon pyrosequencing (bTEFAP). PLoS 
One. 2008;3(10):e3326.
8. Zubair M, Malik A, Ahmad J. Incidence, risk factors for 
amputation among patients with diabetic foot ulcer in a North 
Indian tertiary care hospital. Foot (Edinb). 2012;22(1):24-30.
9. Crouzet J, Lavigne JP, Richard JL, Sotto A, Nîmes 
University Hospital Working Group on the Diabetic Foot 
(GP30). Diabetic foot infection: a critical review of recent 
randomized clinical trials on antibiotic therapy. Int J Infect 
Dis. 2011;15(9):e601-10.
10. Murali TS, Paul B, Parikh H, Singh RP, Kavitha S, Bhat MK, 
et al. Genome sequences of four clinical Staphylococcus 
aureus strains with diverse drug resistance profiles isolated 
from diabetic foot ulcers. Genome Announc. 2014;2(2).
11. Zubair M, Malik A, Ahmad J. Prevalence of metallo-ß-
lactamase-producing Pseudomonas aeruginosa isolated 
from diabetic foot ulcer patients. Diabetes Metab Syndr. 
2011;5(2):90-2.
12. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, 
Chaudhry R. A clinico-microbiological study of diabetic 
foot ulcers in an Indian tertiary care hospital. Diabetes Care. 
2006;29(8):1727-32.
13. Basu S, Ramchuran Panray T, Bali Singh T, Gulati AK, 
Shukla VK. A prospective, descriptive study to identify the 
microbiological profile of chronic wounds in outpatients. 
Ostomy Wound Manage. 2009;55(1):14-20.
14. Chand G, Mishra AK, Kumar S, Agarwal A. Diabetic foot. 
Clinical Queries. Nephrology. 2012;0102:144-50.
15. Richard JL, Sotto A, Jourdan N, Combescure C, 
Vannereau D, Rodier M, et al. Risk factors and healing 
impact of multidrug-resistant bacteria in diabetic foot ulcers. 
Diabetes Metab. 2008;34:363-9.
16. Gardner SE, Hillis SL, Heilmann K, Segre JA, Grice EA. 
The neuropathic diabetic foot ulcer microbiome is associated 
with clinical factors. Diabetes. 2013;62(3):923-30.
17. Yates C, May K, Hale T, Allard B, Rowlings N, Freeman A, 
et al. Wound chronicity, inpatient care, and chronic kidney 
disease predispose to MRSA infection in diabetic foot ulcers. 
Diabetes Care. 2009;32(10):1907-9.
18. Ambrosh A, Haefner S, Jude E, Lobmann R. Diabetic 
foot infections: microbiological aspects, current and 
future antibiotic therapy focussing on methicillin-resistant 
Staphyloccus aureus. Int Wound J. 2011;8(6):567-77.
19. Otto M. Staphylococcus aureus toxins. Curr Opin Microbiol. 
2014;17:32-7.
20. Djahmi N, Messad N, Nedjai S, Moussaoui A, Mazouz D, 
Richard JL, et al. Molecular epidemiology of Staphylococcus 
aureus strains isolated from inpatients with infected diabetic 
foot ulcers in an Algerian University Hospital. Clin Microbiol 
Infect. 2013;19(9):E398-404.
21. Bowling FL, Jude EB, Boulton AJ. MRSA and diabetic foot 
wounds: contaminating or infecting organisms? Curr Diab 
Rep. 2009;9(6):440-4.
22. Goldstein EJ, Citron DM, Nesbit CA. Diabetic foot 
infections. Bacteriology and activity of 10 oral antimicrobial 
agents against bacteria isolated from consecutive cases. 
Diabetes Care. 1996;19(6):638-41.
23. Lipsky BA, Richard JL, Lavigne JP. Diabetic foot ulcer 
microbiome: one small step for molecular microbiology one 
giant leap for understanding diabetic foot ulcers? Diabetes. 
2013;62(3):679-81.
24. Huygens F, Inman-Bamber J, Nimmo GR, Munckhof W, 
Schooneveldt J, Harrison B, et al. Staphylococcus aureus 
genotyping using novel real-time PCR formats. J Clin 
Microbiol. 2006;44(10):3712-9.
25. Ge Y, MacDonald D, Hait H, Lipsky B, Zasloff M, 
Holroyd K. Microbiological profile of infected diabetic foot 
ulcers. Diabet Med. 2002;19(12):1032-4.
26. El-Tahawy AT. Bacteriology of diabetic foot. Saudi Med J. 
2000;21(4):344-7.
27. Tentolouris N, Jude EB, Smirnof I, Knowles EA, 
Boulton AJ. Methicillin-resistant Staphylococcus aureus: 
an increasing problem in a diabetic foot clinic. Diabet Med. 
1999;16(9):767-71.
Sandhu S et al. Int J Basic Clin Pharmacol. 2014 Dec;3(6):978-982
 International Journal of Basic & Clinical Pharmacology | November-December 2014 | Vol 3 | Issue 6 Page 982
28. Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. 
Bacteriological study of diabetic foot infections. J Diabetes 
Complications. 2005;19(3):138-41.
29. Stanaway S, Johnson D, Moulik P, Gill G. Methicillin-resistant 
Staphylococcus aureus (MRSA) isolation from diabetic foot 
ulcers correlates with nasal MRSA carriage. Diabetes Res 
Clin Pract. 2007;75(1):47-50.
30. Aragón-Sánchez FJ, Cabrera-Galván JJ, Quintana-Marrero Y, 
Hernández-Herrero MJ, Lázaro-Martínez JL, 
García-Morales E, et al. Outcomes of surgical treatment 
of diabetic foot osteomyelitis: a series of 185 patients 
with histopathological confirmation of bone involvement. 
Diabetologia. 2008;51(11):1962-70.
31. Mehta VJ, Kikani KM, Mehta SJ. Microbiological profile of 
diabetic foot ulcers and its antibiotic susceptibility pattern 
in a teaching hospital, Gujarat. Int J Basic Clin Pharmacol. 
2014;3:92-5.
doi: 10.5455/2319-2003.ijbcp20141201
Cite this article as: Sandhu S, Rathnayake IU, Huygens F. 
Prevalence of methicillin resistance and virulence 
determinants of Staphylococcus aureus in diabetic foot 
ulcers. Int J Basic Clin Pharmacol 2014;3:978-82.
